熱門資訊> 正文
Roivant Sciences制定5亿美元股票回购计划
2025-06-25 19:51
- Roivant Sciences (NASDAQ:ROIV) has set a stock repurchase program to buy back up to $500M of its common shares.
- The program will be funded with available cash and cash equivalents on hand and does not have an expiration date.
- This new authorization is in addition to the $1.5B common share repurchase program announced in April 2024, which had ~$205M of remaining capacity as of March 31, 2025 and has since been fully exhausted.
More on Roivant Sciences
- Roivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call Transcript
- Roivant Sciences Ltd. 2024 Q4 - Results - Earnings Call Presentation
- Roivant Sciences: Primed For Growth With A De-Risked Pipeline
- Roivant signals pivotal data readouts and potential multi-blockbuster launches over next 36 months
- Immunovant makes leadership changes
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
